These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 36860127)

  • 21. Double positivity for antineutrophil cytoplasmic antibody (ANCA) and anti-glomerular basement membrane antibody could predict end-stage renal disease in ANCA-associated vasculitis: a monocentric pilot study.
    Yoo BW; Ahn SS; Jung SM; Song JJ; Park YB; Lee SW
    Clin Rheumatol; 2020 Mar; 39(3):831-840. PubMed ID: 31802348
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PEXIVAS: The End of Plasmapheresis for ANCA-Associated Vasculitis?
    De Vriese AS; Fervenza FC
    Clin J Am Soc Nephrol; 2021 Feb; 16(2):307-309. PubMed ID: 32963016
    [No Abstract]   [Full Text] [Related]  

  • 23. Characteristics and outcome of crescentic glomerulonephritis in patients with both antineutrophil cytoplasmic antibody and anti-glomerular basement membrane antibody.
    Srivastava A; Rao GK; Segal PE; Shah M; Geetha D
    Clin Rheumatol; 2013 Sep; 32(9):1317-22. PubMed ID: 23624587
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [PEXIVAS-The kiss of death for plasma exchange in ANCA-associated vasculitis?].
    Löffler C; Hellmich B
    Z Rheumatol; 2020 Nov; 79(9):910-911. PubMed ID: 33025026
    [No Abstract]   [Full Text] [Related]  

  • 25. A case of anti-neutrophil cytoplasmic antibody-associated vasculitis with anti-glomerular basement membrane antibodies that was successfully treated with mizoribine as a safe and effective remission maintenance therapy with prednisolone and plasma exchange.
    Ikeda Y; Fukunari K; Uchiumi S; Awanami Y; Kanaya A; Matsumoto K; Fukuda M; Takashima T; Miyazono M; Ikeda Y
    CEN Case Rep; 2020 Feb; 9(1):42-47. PubMed ID: 31612361
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Update to the ASFA guidelines on the use of therapeutic apheresis in ANCA-associated vasculitis.
    Balogun RA; Sanchez AP; Klingel R; Witt V; Aqui N; Meyer E; Padmanabhan A; Pham HP; Schneiderman J; Schwartz J; Wu Y; Zantek ND; Connelly-Smith L; Dunbar NM
    J Clin Apher; 2020 Sep; 35(5):493-499. PubMed ID: 32770558
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [ANCA and anti-MBG double-positive vasculitis: An update on the clinical and therapeutic specificities and comparison with the two eponymous vasculitis].
    Philip R; Dumont A; Le Mauff B; Martinet M; Martin Silva N; de Boysson H; Lobbedez T; Aouba A; Deshayes S
    Rev Med Interne; 2020 Jan; 41(1):21-26. PubMed ID: 31839271
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasma exchange and glucocorticoid dosing for patients with ANCA-associated vasculitis: a clinical practice guideline.
    Zeng L; Walsh M; Guyatt GH; Siemieniuk RAC; Collister D; Booth M; Brown P; Farrar L; Farrar M; Firth T; Fussner LA; Kilian K; Little MA; Mavrakanas TA; Mustafa RA; Piram M; Stamp LK; Xiao Y; Lytvyn L; Agoritsas T; Vandvik PO; Mahr A
    BMJ; 2022 Feb; 376():e064597. PubMed ID: 35217581
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combination treatment with rituximab, low-dose cyclophosphamide and plasma exchange for severe antineutrophil cytoplasmic antibody-associated vasculitis.
    Gulati K; Edwards H; Prendecki M; Cairns TD; Condon M; Galliford J; Griffith M; Levy JB; Tam FWK; Tanna A; Pusey CD; McAdoo SP
    Kidney Int; 2021 Dec; 100(6):1316-1324. PubMed ID: 34560140
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Renal and overall outcomes of double-positive (ANCA and anti-GBM antibodies) patients compared to ANCA-associated vasculitis patients with severe renal involvement: A multicenter retrospective study with systematic renal pathology analysis.
    Clerte M; Philip R; Levi C; Cornec-Le Gall E; Audard V; Huart A; Puéchal X; Touzot M; Rabot N; Thervet É; Aouba A; Karras A
    Scand J Rheumatol; 2022 May; 51(3):205-213. PubMed ID: 34169779
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma exchange in ANCA-associated vasculitis: the pro position.
    Kronbichler A; Shin JI; Wang CS; Szpirt WM; Segelmark M; Tesar V
    Nephrol Dial Transplant; 2021 Jan; 36(2):227-231. PubMed ID: 33374018
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antineutrophil cytoplasmic antibodies in infective endocarditis: a case report and systematic review of the literature.
    Van Gool IC; Kers J; Bakker JA; Rotmans JI; Teng YKO; Bauer MP
    Clin Rheumatol; 2022 Oct; 41(10):2949-2960. PubMed ID: 35732985
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antineutrophil cytoplasmic antibody-associated vasculitis.
    Konda R; Rajasekaran A; Rizk DV
    Curr Opin Nephrol Hypertens; 2024 Sep; 33(5):503-511. PubMed ID: 38785128
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term outcome of patients with ANCA-associated vasculitis treated with plasma exchange: a retrospective, single-centre study.
    Frausová D; Hrušková Z; Lánská V; Lachmanová J; Tesař V
    Arthritis Res Ther; 2016 Jul; 18():168. PubMed ID: 27412443
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pathogenesis and treatment of ANCA-associated vasculitis-a role for complement.
    Noone D; Hebert D; Licht C
    Pediatr Nephrol; 2018 Jan; 33(1):1-11. PubMed ID: 27596099
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effects of plasma exchange in patients with ANCA-associated vasculitis: an updated systematic review and meta-analysis.
    Walsh M; Collister D; Zeng L; Merkel PA; Pusey CD; Guyatt G; Au Peh C; Szpirt W; Ito-Hara T; Jayne DRW;
    BMJ; 2022 Feb; 376():e064604. PubMed ID: 35217545
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Effects of Plasma Exchange on Severe Vasculitis with Diffuse Alveolar Hemorrhage.
    Goto K; Nakai K; Fujii H; Nishi S
    Intern Med; 2017; 56(1):55-59. PubMed ID: 28050000
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Case report: de novo ANCA-associated vasculitis after kidney transplantation treated with rituximab and plasma exchange.
    Sagmeister MS; Weiss M; Eichhorn P; Habicht A; Habersetzer R; Fischereder M; Schönermarck U
    BMC Nephrol; 2018 Oct; 19(1):270. PubMed ID: 30340563
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relevance of histopathological findings for predictive scoring of short-term treatment response to plasma exchange in severe ANCA-associated renal vasculitides.
    Hakroush S; Korsten P; Ströbel P; Tampe B
    Front Immunol; 2024; 15():1340999. PubMed ID: 38380320
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of plasma exchange for antineutrophil cytoplasmic antibody-associated systemic vasculitis: a systematic review and meta-analysis.
    Yamada Y; Harada M; Hara Y; Iwabuchi R; Hashimoto K; Yamamoto S; Kamijo Y
    Arthritis Res Ther; 2021 Jan; 23(1):28. PubMed ID: 33446268
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.